Sarver Vrooman Wealth Advisors

Position in MRK — Merck & Co., Inc.

CIK 2076215 KANSAS CITY, MO

Position in MRK

as of Jun 30, 2026 · filed Jul 2, 2026 Compact

Position Value

$92,391

-$13,825 QoQ

Shares Held

719

-18.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.57%

of 13F equity value

Holder Rank

#3,596

of 3,769 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Sarver Vrooman Wealth Advisors holds $412,483 across 5 Drug Manufacturers - General names. MRK ranks #3 (22.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	284	$102,842
2	JNJ	Johnson & Johnson	381	$96,762
3	MRK	Merck & Co., Inc. This page	719	$92,391
4	GILD	Gilead Sciences, Inc.	613	$77,446
5	BMY	Bristol Myers Squibb Co	747	$43,042

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$92,391	719	-18.6%	Shares	Sole	2026-07-02
2026-03-31	$106,216	883	-8.2%	Shares	Sole	2026-04-15
2025-12-31	$101,260	962	-23.4%	Shares	Sole	2026-04-23
2025-09-30	$105,416	1,256	0.0%	Shares	Sole	2025-10-23
2025-06-30	$99,424	1,256	-5.8%	Shares	Sole	2025-07-09
2025-03-31	$119,650	1,333	—	Shares	Sole	2025-07-08
No filing history on record for this holder in this stock.